论文部分内容阅读
261.PHARMACOKINTICS OF A NOVEL NEUROPATHIC PAIN AGENT, SKL11197, IN RATS AND DOGS
【作 者】
:
【机 构】
:
Drug Development Center,SK LS R&D Park,Daejeon,South Korea
【出 处】
:
2nd Asian Pacific Regional ISSX2nd Asian Pacific Regional IS
【发表日期】
:
2008年1期
其他文献
287.IMPLEMENTATION OF A RAT CASSETTE DOSING APPROACH IN SUPPORT OF PHARMACOKINETIC OPTIMIZATION OF D
会议
290.SIMULTANEOUS DETERMINATION OF FIVE WATER-SOLUBLE COMPONENTS OF DANSHEN INJECTION IN RATS FOR MUL
会议
291.CHARACTERIZATION AND IN SITU INTESTINAL ABSORPTION BEHAVIOR OF TANSHINONE IIA-2-HYDROXYPROPYL-&B
In this paper,the effect of the chemically modified cyclodextrin [2-hydroxypropyl-&beta-cyclodextrin,(HP-&beta-CD)] on the dissolution rate,and intestinal permeability of the tanshinone IIA (TS) was i
会议
292.INCREASED TRANSPORT THROUGH AND DIRECT PROTECTIVE EFFECT AGAINST A DAMAGED BLOOD BRAIN BARRIER O
Previous studies could not explain the paradox between the poor brain distribution and powerful neuroprotective effects of tanshinone ⅡA.We hypothesized in this study that the increased transport thro
会议
293.23-HYDROXYBETULINIC ACID ENHANCES THE CYTOTOXICITY OF CHEMOTHERAPEUTIC AGENTS THROUGH MODULATING
会议
294.A DOUBLE-PEAK PHENOMENON IN THE PHARMACOKINETICS OF THE NOVEL NON-PEPTIDE ANGIOTENSIN TYPE 1 REC
会议